| Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics (NCT03094897) | Wuxi No. 4 People's Hospital | 2017-04-20 |
| Study of Metabolites Markers in Adjuvant Breast Cancer (NCT03367208) | Centre Antoine Lacassagne | 2017-04-12 |
| Hemostatic Profiles of Endocrine Therapies for Breast Cancer (NCT03381963) | University Hospital, Geneva | 2017-04-01 |
| Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer (NCT02948764) | Heidelberg University | 2017-03-08 |
| PemVin vs Vin in Previously Treated Metastatic Breast Cancer (NCT03242616) | Seoul National University Hospital | 2017-02-17 |
| Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score (NCT02476786) | Washington University School of Medicine | 2017-01-17 |
| Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast Cancer (NCT03461588) | Shu lian Wang | 2017-01-01 |
| Efficacy of Preoperative Radiotherapy for Non-responder Patients After Neoadjuvant Chemotherapy (NCT05274594) | Istanbul Breast Society | 2017-01-01 |
| An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer (NCT03099200) | Hoffmann-La Roche | 2016-12-12 |
| Delphinus SoftVue Prospective Case Collection - ARM 2 (NCT02977247) | Delphinus Medical Technologies, Inc. | 2016-12-06 |
| Low Dose Tomosynthesis Compared to Traditional Tomosynthesis (NCT02771444) | Philips Digital Mammography Sweden AB | 2016-12-01 |
| Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment (NCT02887196) | Pennington Biomedical Research Center | 2016-12-01 |
| LOL: It's All Improv After Cancer! The Impact of Improvisational Comedy on Well-Being Among Patients With Cancer (NCT02892006) | Cedars-Sinai Medical Center | 2016-11-30 |
| Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET (NCT02850302) | Centre Georges Francois Leclerc | 2016-11-08 |
| Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer (NCT02541435) | St. Olavs Hospital | 2016-11-01 |
| Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer (NCT02831582) | Ohio State University Comprehensive Cancer Center | 2016-10-12 |
| Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast Cancer (NCT02681120) | Tarah J Ballinger, MD | 2016-10-07 |
| A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast Cancer (NCT02707510) | Cedars-Sinai Medical Center | 2016-10-01 |
| Cervical Motor Control in Long-term Breast Cancer Survivors (NCT02825810) | Universidad de Granada | 2016-10-01 |
| Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast Cancer (NCT02740491) | Centre Hospitalier Universitaire de Nīmes | 2016-09-12 |
| 18F-FSPG PET/CT Imaging in Patients With Cancers (NCT03144622) | National Taiwan University Hospital | 2016-09-06 |
| A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations (NCT02950064) | Placon Therapeutics | 2016-09-01 |
| Nuevo Amanecer II: Translating a Stress Management Program for Latinas (NCT02931552) | University of California, San Francisco | 2016-09-01 |
| TR(ACE) Assay Clinical Specimen Study (NCT02934360) | Biological Dynamics | 2016-09-01 |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors (NCT02897778) | Syndax Pharmaceuticals | 2016-08-24 |
| Breast Reconstruction Outcomes With and Without StratticE (NCT02608593) | Manchester University NHS Foundation Trust | 2016-08-19 |
| Pilot Study of Bisphosphonates for Breast Cancer (NCT02781805) | University of Wisconsin, Madison | 2016-08-05 |
| ICG and Blue Dye Guided Sentinel Lymph Node Biopsy in Patients Underwent Neoadjuvant Therapy (NCT02869815) | Peking University People's Hospital | 2016-08-01 |
| Behavioral Symptom Management Program for Breast Cancer in Singapore and The US (NCT02865148) | Duke-NUS Graduate Medical School | 2016-08-01 |
| Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy (NCT02756364) | Calithera Biosciences, Inc | 2016-07-28 |
| Integral Strategy to Supportive Care in Breast Cancer Patients (NCT02817724) | Universidad de Granada | 2016-07-01 |
| Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective Trial (NCT02818946) | Duke University | 2016-07-01 |
| A Registry Study of Breast Microseed Treatment (NCT02701244) | Concure Oncology-Breast Microseed Inc. | 2016-07-01 |
| Reader Study for Image Quality of Cone Beam Breast CT System (NCT02864667) | Koning Corporation | 2016-06-01 |
| Immunostimulating Interstitial Laser Thermotherapy in Breast Cancer (NCT03039127) | Clinical Laserthermia Systems AB | 2016-06-01 |
| Long-term Improvement of Quality of Life in Breast Cancer Patients With Quality of Life Diagnosis and Therapy (NCT04334096) | Tumor Center Regensburg | 2016-05-30 |
| End-of-Life Care for African Americans (NCT02320123) | University of Texas Southwestern Medical Center | 2016-05-23 |
| Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer (NCT02781259) | Samsung Medical Center | 2016-05-01 |
| Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors (NCT02406794) | University of Malaga | 2016-05-01 |
| An Intervention Programme to Reduce Cognitive Impairment Due to Cancer (NCT02581709) | Queen's University, Belfast | 2016-05-01 |
| Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients (NCT02922244) | Chulabhorn Cancer Center | 2016-05-01 |
| Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D Printing (NCT04929197) | Taipei Medical University Hospital | 2016-04-21 |
| PERCIST Criteria for Response Evaluation With Solid Tumors (NCT02765620) | Tianjin Medical University Cancer Institute and Hospital | 2016-04-01 |
| NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer (NCT02689921) | Midwestern Regional Medical Center | 2016-04-01 |
| A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC (NCT02771795) | Samsung Bioepis Co., Ltd. | 2016-04-01 |
| Pectoral Nerves Blocks for Chronic Pain (NCT02719795) | First Affiliated Hospital Xi'an Jiaotong University | 2016-04-01 |
| Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study (NCT02954900) | Columbia University | 2016-03-15 |
| Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence (NCT02657993) | Icahn School of Medicine at Mount Sinai | 2016-03-01 |
| A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression (NCT02512237) | Zhejiang Medicine Co., Ltd. | 2016-03-01 |
| Effect of Low vs Moderate-intensity Endurance Exercise on Physical Functioning Among Breast Cancer Survivors (NCT02982564) | University of Puerto Rico | 2016-03-01 |
| Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave), NEOELASTO (NCT02834494) | Institut Curie | 2016-02-22 |
| Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer (NCT02690480) | Spanish Breast Cancer Research Group | 2016-02-17 |
| Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse (NCT02686918) | Institut de Cancérologie de la Loire | 2016-02-01 |
| Sienna+® Injection Time Study 4 Arms (NCT02612870) | Kantonsspital Baden | 2016-02-01 |
| Limiting Chemotherapy Side Effects by Using Moxa (NCT02781155) | East and North Hertfordshire NHS Trust | 2016-02-01 |
| Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice (NCT02655159) | Celgene Corporation | 2016-01-01 |
| The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing Mastectomy (NCT02627560) | St. Olavs Hospital | 2016-01-01 |
| The Digital Breast Tomosynthesis Trial in Bergen (NCT02835625) | Norwegian Institute of Public Health | 2016-01-01 |
| Study of Tumor RNA Disruption Assay™ (RDA) (NCT02239315) | University of Toronto | 2015-12-01 |
| Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors (NCT02611544) | Indiana University | 2015-12-01 |
| Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host (NCT02732860) | University Health Network, Toronto | 2015-12-01 |
| The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors (NCT02510430) | University of Wisconsin, Madison | 2015-11-30 |
| Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing Positively (NCT02650661) | Seoul National University Hospital | 2015-11-23 |
| Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer (NCT02489448) | Yale University | 2015-11-01 |
| Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma (NCT02603016) | Chinese PLA General Hospital | 2015-11-01 |
| Bright Light on Fatigue in Women Being Treated for Breast Cancer (NCT02658708) | Washington University School of Medicine | 2015-10-12 |
| Patient Reported Outcomes Using Mepitel Film During Radiotherapy (NCT06133218) | Odense University Hospital | 2015-10-01 |
| Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer (NCT02489409) | Xinjiang Medical University | 2015-10-01 |
| Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer (NCT02549677) | Ruijin Hospital | 2015-10-01 |
| Breast Cancer Chemotherapy Risk Prediction Mathematical Model (NCT02547545) | First Affiliated Hospital Xi'an Jiaotong University | 2015-09-01 |
| Preventive Intervention Against Lymphedema After Breast Cancer Surgery (NCT02518477) | Danish Cancer Society | 2015-09-01 |
| Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium (NCT02652975) | University of Aarhus | 2015-09-01 |
| Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475 (NCT02303366) | Peter MacCallum Cancer Centre, Australia | 2015-09-01 |
| EXercise Influence on Taxane Side Effects (EXIT) Study (NCT02473861) | University of British Columbia | 2015-08-01 |
| SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial (NCT02521623) | Aarhus University Hospital | 2015-08-01 |
| Impact of LOFT Therapy™ on Breast Cancer Survivors (NCT02491957) | Kathy Miller | 2015-07-28 |
| MRI and Early Decision-making in Chemotherapy for Breast Cancer (NCT02449824) | University of Leeds | 2015-07-01 |
| TME Neoadjuvant Breast Registry (NCT02596724) | Targeted Medical Education | 2015-07-01 |
| Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients (NCT02403037) | The Hong Kong Polytechnic University | 2015-07-01 |
| Mobile Health (mHealth) Black Women With Breast Cancer (NCT02463474) | University of Florida | 2015-07-01 |
| Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... (NCT02484404) | National Cancer Institute (NCI) | 2015-06-29 |
| Project Connect Online: An Internet-based Intervention for Women With Breast Cancer (NCT02866994) | Jonsson Comprehensive Cancer Center | 2015-06-04 |
| Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer (NCT02258451) | Bayer | 2015-06-04 |
| Nano MRI on 7 Tesla in Rectal and Breast Cancer (NCT02751606) | Radboud University Medical Center | 2015-06-01 |
| Clinical Trial With Two Physical Therapy Protocols After Breast Cancer Surgery and Immediate Reconstruction (NCT02480842) | Federal University of São Paulo | 2015-06-01 |
| Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients (NCT02583828) | Capital Medical University | 2015-06-01 |
| The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) (NCT02400190) | University of Michigan Rogel Cancer Center | 2015-05-27 |
| Reversing Therapy Resistance With Epigenetic-Immune Modification (NCT02395627) | University of California, San Francisco | 2015-05-04 |
| "Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment " (NCT02530424) | Fondazione Michelangelo | 2015-05-01 |
| Targeting the Hippo Transducer TAZ in Breast Cancer With Statins (NCT02416427) | Regina Elena Cancer Institute | 2015-05-01 |
| Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin (NCT02423356) | Daniel Rushing | 2015-04-23 |
| Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors (NCT02485626) | The Netherlands Cancer Institute | 2015-04-01 |
| MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast Tissue (NCT02013726) | Gamma Medica, Inc. | 2015-04-01 |
| An Online Enhanced Education Tool for Young Women Newly Diagnosed With Breast Cancer (NCT02340494) | Women's College Hospital | 2015-04-01 |
| Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy (NCT02271828) | Maastricht University Medical Center | 2015-04-01 |
| A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4] (NCT02297438) | Pfizer | 2015-03-23 |
| Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant (NCT02374099) | Celgene | 2015-03-13 |
| Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer (NCT02258464) | Bayer | 2015-03-02 |
| Efficacy and Safety Study With MYL-1401H and Neulasta (NCT02467868) | Mylan Inc. | 2015-03-01 |
| A Trial of a New Magnetic Breast Marking Clip (NCT02378558) | Antonios Likourezos | 2015-03-01 |